| 1 | Investigation in blood-brain barrier integrity and susceptibility to immune cell penetration in a mouse model of Dravet syndrome | 2.4 | 4 | Citations (PDF) |
| 2 | Daytime DNase-I Administration Protects Mice From Ischemic Stroke Without Inducing Bleeding or tPA-Induced Hemorrhagic Transformation, Even With Aspirin Pretreatment | 5.9 | 22 | Citations (PDF) |
| 3 | Gut Microbiota, Bacterial Translocation, and Stroke: Current Knowledge and Future Directions | 3.4 | 13 | Citations (PDF) |
| 4 | Tumor Necrosis Factor (TNF)-α-Stimulated Gene 6 (TSG-6): A Promising Immunomodulatory Target in Acute Neurodegenerative Diseases | 4.4 | 22 | Citations (PDF) |
| 5 | Consensus Recommendations for Standardized Data Elements, Scales, and Time Segmentations in Studies of Human Circadian/Diurnal Biology and Stroke | 5.9 | 19 | Citations (PDF) |
| 6 | Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice | 3.4 | 6 | Citations (PDF) |
| 7 | Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice | 5.9 | 20 | Citations (PDF) |
| 8 | Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration | 3.7 | 10 | Citations (PDF) |
| 9 | Neutrophil Extracellular Trap Targeting Protects Against Ischemic Damage After Fibrin-Rich Thrombotic Stroke Despite Non-Reperfusion | 4.9 | 32 | Citations (PDF) |
| 10 | First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers | 5.5 | 57 | Citations (PDF) |
| 11 | Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa | 8.5 | 9 | Citations (PDF) |
| 12 | MO652: Comparison of Two Medium Cut-Off Dialysers Versus Online Haemodiafiltration Regarding Albumin Loss and the Removal of a Broad Spectrum of Molecules | 0.8 | 0 | Citations (PDF) |
| 13 | The neurovascular unit and systemic biology in stroke — implications for translation and treatment | 28.6 | 118 | Citations (PDF) |
| 14 | Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases | 5.9 | 13 | Citations (PDF) |
| 15 | Diurnal Differences in Immune Response in Brain, Blood and Spleen After Focal Cerebral Ischemia in Mice | 5.9 | 26 | Citations (PDF) |
| 16 | Endothelial cells regulate astrocyte to neural progenitor cell trans-differentiation in a mouse model of stroke | 13.7 | 46 | Citations (PDF) |
| 17 | Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI | 4.7 | 14 | Citations (PDF) |
| 18 | Post-stroke Neurogenesis: Friend or Foe? | 3.6 | 54 | Citations (PDF) |
| 19 | Effective glutamate clearance from the systemic circulation by hemodialysis: Potential relevance for cerebral ischemia management | 1.8 | 2 | Citations (PDF) |
| 20 | Circadian Biology and Stroke | 5.9 | 82 | Citations (PDF) |
| 21 | Tlr2 Gene Deletion Delays Retinal Degeneration in Two Genetically Distinct Mouse Models of Retinitis Pigmentosa | 4.4 | 11 | Citations (PDF) |
| 22 | Pathophysiological and pharmacological relevance of TLR4 in peripheral immune cells after stroke 2021, 228, 107933 | | 26 | Citations (PDF) |
| 23 | New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases | 3.9 | 21 | Citations (PDF) |
| 24 | Role of TLR4 in Neutrophil Dynamics and Functions: Contribution to Stroke Pathophysiology | 4.9 | 32 | Citations (PDF) |
| 25 | Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation | 23.5 | 267 | Citations (PDF) |
| 26 | Delayed Effects of Acute Reperfusion on Vascular Remodeling and Late-Phase Functional Recovery After Stroke | 2.7 | 13 | Citations (PDF) |
| 27 | Role of TLR4 (Toll-Like Receptor 4) in N1/N2 Neutrophil Programming After Stroke | 5.9 | 146 | Citations (PDF) |
| 28 | Lack of the aryl hydrocarbon receptor accelerates aging in mice | 0.6 | 49 | Citations (PDF) |
| 29 | Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance | 5.9 | 147 | Citations (PDF) |
| 30 | Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke | 4.5 | 29 | Citations (PDF) |
| 31 | Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice | 10.6 | 126 | Citations (PDF) |
| 32 | Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa | 14.1 | 39 | Citations (PDF) |
| 33 | Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage | 10.8 | 75 | Citations (PDF) |
| 34 | Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice | 5.9 | 33 | Citations (PDF) |
| 35 | Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions | 4.7 | 108 | Citations (PDF) |
| 36 | TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models | 10.2 | 72 | Citations (PDF) |
| 37 | AhR Deletion Promotes Aberrant Morphogenesis and Synaptic Activity of Adult-Generated Granule Neurons and Impairs Hippocampus-Dependent MemoryENeuro, 2018, 5, ENEURO.0370-17.2018 | 2.1 | 39 | Citations (PDF) |
| 38 | Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke | 5.9 | 64 | Citations (PDF) |
| 39 | Specific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study | 3.4 | 44 | Citations (PDF) |
| 40 | Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia | 4.5 | 77 | Citations (PDF) |
| 41 | Test repositioning for functional assessment of neurological outcome after experimental stroke in mice | 2.3 | 16 | Citations (PDF) |
| 42 | Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke | 5.9 | 47 | Citations (PDF) |
| 43 | Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography | 4.7 | 25 | Citations (PDF) |
| 44 | Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke | 5.9 | 28 | Citations (PDF) |
| 45 | Complexity of the cell–cell interactions in the innate immune response after cerebral ischemia | 2.5 | 20 | Citations (PDF) |
| 46 | Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia | 9.0 | 67 | Citations (PDF) |
| 47 | Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[ 18 F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke | 5.3 | 6 | Citations (PDF) |
| 48 | The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins | 2.3 | 14 | Citations (PDF) |
| 49 | L-Kynurenine/Aryl Hydrocarbon Receptor Pathway Mediates Brain Damage After Experimental Stroke | 18.0 | 131 | Citations (PDF) |
| 50 | Toll‐like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia | 0.6 | 63 | Citations (PDF) |
| 51 | Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways | 2.9 | 73 | Citations (PDF) |
| 52 | Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways | 2.3 | 28 | Citations (PDF) |
| 53 | Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia | 0.3 | 14 | Citations (PDF) |
| 54 | Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia | 0.3 | 1 | Citations (PDF) |
| 55 | miRNA expression is modulated over time after focal ischaemia: up‐regulation of miR–347 promotes neuronal apoptosis | 5.3 | 64 | Citations (PDF) |
| 56 | N2 Neutrophils, Novel Players in Brain Inflammation After Stroke | 5.9 | 351 | Citations (PDF) |
| 57 | Neuronal Excitotoxicity after Carotid Angioplasty and Stent Placement Procedures | 8.7 | 3 | Citations (PDF) |
| 58 | Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury | 2.4 | 22 | Citations (PDF) |
| 59 | Citicoline (CDP‐choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke | 3.8 | 56 | Citations (PDF) |
| 60 | Oct-2 Transcription Factor Binding Activity and Expression Up-Regulation in Rat Cerebral Ischaemia is Associated with a Diminution of Neuronal Damage In Vitro | 3.6 | 12 | Citations (PDF) |
| 61 | Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | 5.9 | 205 | Citations (PDF) |
| 62 | Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion | 3.5 | 56 | Citations (PDF) |
| 63 | Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke | 2.3 | 51 | Citations (PDF) |
| 64 | Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation | 3.5 | 43 | Citations (PDF) |
| 65 | Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury | 9.0 | 56 | Citations (PDF) |
| 66 | Functional cGMP‐gated channels in cerebellar granule cells | 4.1 | 12 | Citations (PDF) |
| 67 | Longitudinal studies of ischemic penumbra by using 18 F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats | 4.4 | 58 | Citations (PDF) |
| 68 | Implication of the toll‐like receptor 4 pathway in the response to interferon‐β in multiple sclerosis | 6.6 | 38 | Citations (PDF) |
| 69 | Neuroprotection and Recovery | 5.9 | 54 | Citations (PDF) |
| 70 | A Mouse Model of Hemorrhagic Transformation by Delayed Tissue Plasminogen Activator Administration After In Situ Thromboembolic Stroke | 5.9 | 86 | Citations (PDF) |
| 71 | The Cannabinoid
WIN55212-2
Promotes Neural Repair After Neonatal Hypoxia–Ischemia | 5.9 | 43 | Citations (PDF) |
| 72 | Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model | 2.3 | 23 | Citations (PDF) |
| 73 | Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome | 2.4 | 69 | Citations (PDF) |
| 74 | Synthesis of Lipoxin A 4 by 5-Lipoxygenase Mediates PPARγ-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke | 3.7 | 123 | Citations (PDF) |
| 75 | Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia | 4.0 | 132 | Citations (PDF) |
| 76 | Toll‐like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning | 3.8 | 120 | Citations (PDF) |
| 77 | Plasma levels of 15d‐PGJ 2 are not altered in multiple sclerosis | 3.5 | 8 | Citations (PDF) |
| 78 | Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆ | 15.4 | 104 | Citations (PDF) |
| 79 | Aumento de expresión y actividad de MMP-9 en rinosinusitis crónica con poliposis nasal | 0.6 | 10 | Citations (PDF) |
| 80 | Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil | 4.3 | 6 | Citations (PDF) |
| 81 | Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke | 5.1 | 41 | Citations (PDF) |
| 82 | Increased Expression and Activity of MMP-9in Chronic Rhinosinusitis With Nasal Polyposis | 0.1 | 0 | Citations (PDF) |
| 83 | Toll-Like Receptor 4 Is Involved in Subacute Stress–Induced Neuroinflammation and in the Worsening of Experimental Stroke | 5.9 | 176 | Citations (PDF) |
| 84 | Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke | 18.0 | 101 | Citations (PDF) |
| 85 | The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats | 2.2 | 69 | Citations (PDF) |
| 86 | Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke | 18.0 | 595 | Citations (PDF) |
| 87 | The Increase of Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke Is Associated With Good Outcome | 5.9 | 220 | Citations (PDF) |
| 88 | Statin treatment withdrawal in ischemic stroke | 1.0 | 318 | Citations (PDF) |
| 89 | Involvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in rats | 1.0 | 76 | Citations (PDF) |
| 90 | A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke | 5.1 | 81 | Citations (PDF) |
| 91 | The Role of PPARγ on Restoration of Colonic Homeostasis After Experimental Stress-Induced Inflammation and Dysfunction | 0.9 | 100 | Citations (PDF) |
| 92 | Ischemic Preconditioning Reveals that GLT1/EAAT2 Glutamate Transporter is a Novel PPARγ Target Gene Involved in Neuroprotection | 4.7 | 139 | Citations (PDF) |
| 93 | TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning | 2.3 | 34 | Citations (PDF) |
| 94 | The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats | 2.3 | 43 | Citations (PDF) |
| 95 | Hyperthermia is a surrogate marker of inflammation‐mediated cause of brain damage in acute ischaemic stroke | 7.3 | 59 | Citations (PDF) |
| 96 | Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms | 4.7 | 109 | Citations (PDF) |
| 97 | New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke | 1.0 | 55 | Citations (PDF) |
| 98 | TNF–α converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis | 3.4 | 19 | Citations (PDF) |
| 99 | Characterization of the Neuroprotective Effect of the Cannabinoid Agonist WIN-55212 in an In Vitro Model of Hypoxic-Ischemic Brain Damage in Newborn Rats | 2.2 | 102 | Citations (PDF) |
| 100 | Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke | 1.0 | 57 | Citations (PDF) |
| 101 | A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke | 9.3 | 95 | Citations (PDF) |
| 102 | The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke | 1.8 | 69 | Citations (PDF) |
| 103 | Immature rat brain slices exposed to oxygen–glucose deprivation as an in vitro model of neonatal hypoxic–ischemic encephalopathy | 2.2 | 38 | Citations (PDF) |
| 104 | TNFR1 Upregulation Mediates Tolerance after Brain Ischemic Preconditioning | 4.7 | 86 | Citations (PDF) |
| 105 | Dual role of nitric oxide in adult neurogenesis | 6.0 | 72 | Citations (PDF) |
| 106 | Mitochondrial respiratory chain and free radical generation in stroke | 3.7 | 222 | Citations (PDF) |
| 107 | The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats | 2.8 | 35 | Citations (PDF) |
| 108 | The Prediction of Malignant Cerebral Infarction by Molecular Brain Barrier Disruption Markers | 5.9 | 141 | Citations (PDF) |
| 109 | Increased Plasma Levels of 15-Deoxy Δ Prostaglandin J 2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic Stroke | 5.9 | 67 | Citations (PDF) |
| 110 | Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport | 5.1 | 137 | Citations (PDF) |
| 111 | Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia | 5.1 | 92 | Citations (PDF) |
| 112 | Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats | 5.4 | 105 | Citations (PDF) |
| 113 | In Vitro Ischemic Tolerance Involves Upregulation of Glutamate Transport Partly Mediated by the TACE/ADAM17-Tumor Necrosis Factor-α Pathway | 3.7 | 125 | Citations (PDF) |
| 114 | Activity of Inducible and Neuronal Nitric Oxide Synthases in Colonic Mucosa Predicts Progression of Ulcerative Colitis | 0.7 | 32 | Citations (PDF) |
| 115 | TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress | 3.5 | 29 | Citations (PDF) |
| 116 | Role of nitric oxide after brain ischaemia | 2.8 | 240 | Citations (PDF) |
| 117 | Stress Increases Susceptibility to Oxidative/Nitrosative Mucosal Damage in an Experimental Model of Colitis in Rats | 2.1 | 25 | Citations (PDF) |
| 118 | Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats | 2.5 | 63 | Citations (PDF) |
| 119 | Postnatal changes in the nitric oxide system of the rat cerebral cortex after hypoxia during delivery | 2.1 | 31 | Citations (PDF) |
| 120 | The release of tumor necrosis factor–α is associated with ischemic tolerance in human stroke | 6.6 | 90 | Citations (PDF) |
| 121 | Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress | 3.5 | 64 | Citations (PDF) |
| 122 | L-Arginine Levels in Blood as a Marker of Nitric Oxide–Mediated Brain Damage in Acute Stroke: A Clinical and Experimental Study | 4.7 | 40 | Citations (PDF) |
| 123 | Neuroprotective effects of aspirin in patients with acute cerebral infarction | 1.9 | 37 | Citations (PDF) |
| 124 | Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke | 0.6 | 55 | Citations (PDF) |
| 125 | Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain | 5.4 | 135 | Citations (PDF) |
| 126 | Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke | 5.9 | 367 | Citations (PDF) |
| 127 | Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats | 1.5 | 35 | Citations (PDF) |
| 128 | Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies | 1.9 | 13 | Citations (PDF) |
| 129 | Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide | 2.5 | 39 | Citations (PDF) |
| 130 | TACE/ADAM17–TNF-α Pathway in Rat Cortical Cultures after Exposure to Oxygen–Glucose Deprivation or Glutamate | 4.7 | 59 | Citations (PDF) |
| 131 | Upregulation of TACE/ADAM17 after Ischemic Preconditioning is Involved in Brain Tolerance | 4.7 | 56 | Citations (PDF) |
| 132 | Upregulation of TACE/ADAM17 After Ischemic Preconditioning Is Involved in Brain Tolerance | 4.7 | 25 | Citations (PDF) |
| 133 | IMPLICATION OF TNF-α CONVERTASE (TACE/ADAM17) IN INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION AND INFLAMMATION IN AN EXPERIMENTAL MODEL OF COLITIS | 3.5 | 66 | Citations (PDF) |
| 134 | N-(3-(Aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats | 4.5 | 42 | Citations (PDF) |
| 135 | Up-regulation of TNF-α convertase (TACE/ADAM17) after oxygen–glucose deprivation in rat forebrain slices | 4.3 | 62 | Citations (PDF) |
| 136 | Chronic Stress Induces the Expression of Inducible Nitric Oxide Synthase in Rat Brain Cortex | 3.8 | 211 | Citations (PDF) |
| 137 | Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor κB‐mediated mechanisms | 3.8 | 173 | Citations (PDF) |
| 138 | Glutathione Depletion, Lipid Peroxidation and Mitochondrial Dysfunction Are Induced by Chronic Stress in Rat Brain | 5.4 | 346 | Citations (PDF) |
| 139 | The Increase in TNF-α Levels Is Implicated in NF-κB Activation and Inducible Nitric Oxide Synthase Expression in Brain Cortex after Immobilization Stress | 5.4 | 221 | Citations (PDF) |
| 140 | Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats | 3.8 | 81 | Citations (PDF) |
| 141 | Fructose-1,6-bisphosphate inhibits the expression of inducible nitric oxide synthase caused by oxygen-glucose deprivation through the inhibition of glutamate release in rat forebrain slices | 2.6 | 19 | Citations (PDF) |
| 142 | Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal | 2.8 | 70 | Citations (PDF) |
| 143 | Inducible Nitric Oxide Synthase Activity Is Expressed Not Only in Inflamed But Also in Normal Colonic Mucosa in Patients With Ulcerative Colitis: A Potential Prognostic Marker | 0.7 | 10 | Citations (PDF) |
| 144 | Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices | 4.3 | 60 | Citations (PDF) |
| 145 | Inhibitors of tace decrease iNOS expression and inflammation in an experimental model of colitis in rats | 0.9 | 0 | Citations (PDF) |
| 146 | Implication of Glutamate in the Expression of Inducible Nitric Oxide Synthase After Oxygen and Glucose Deprivation in Rat Forebrain Slices | 3.8 | 102 | Citations (PDF) |
| 147 | Down-Regulation of Neuronal Nitric Oxide Synthase by Nitric Oxide After Oxygen-Glucose Deprivation in Rat Forebrain Slices | 3.8 | 41 | Citations (PDF) |
| 148 | Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck | 1.4 | 38 | Citations (PDF) |
| 149 | Use of brain slices in the study of pathogenic role of inducible nitric oxide synthase in cerebral ischemia-reperfusion | 0.0 | 19 | Citations (PDF) |
| 150 | Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones | 4.3 | 35 | Citations (PDF) |
| 151 | Protective effect of N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen–glucose deprivation | 4.3 | 34 | Citations (PDF) |
| 152 | Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat 1998, 43, 75-88 | | 118 | Citations (PDF) |
| 153 | Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices | 3.5 | 113 | Citations (PDF) |
| 154 | Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP | 4.3 | 41 | Citations (PDF) |
| 155 | Peroxvnitrite Causes Aspartate Release from Dissociated Rat Cerebeliar Granule Neurones | 2.6 | 12 | Citations (PDF) |
| 156 | Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide | 4.3 | 20 | Citations (PDF) |
| 157 | Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose | 3.8 | 331 | Citations (PDF) |
| 158 | cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. | 7.5 | 446 | Citations (PDF) |
| 159 | Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice | 2.8 | 5 | Citations (PDF) |
| 160 | Correlation between brain nitric oxide synthase activity and opiate withdrawal | 2.6 | 46 | Citations (PDF) |
| 161 | The Ontogeny of Cerebral and Cerebellar Nitric Oxide Synthase in the Guinea Pig and Rat | 2.2 | 69 | Citations (PDF) |
| 162 | The formation of nitric oxide donors from peroxynitrite | 6.3 | 185 | Citations (PDF) |
| 163 | Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity | 4.3 | 29 | Citations (PDF) |
| 164 | Inhibition by Lamotrigine of the Generation of Nitric Oxide in Rat Forebrain Slices | 3.8 | 46 | Citations (PDF) |
| 165 | Induction of calcium-dependent nitric oxide synthases by sex hormones. | 7.5 | 1,116 | Citations (PDF) |
| 166 | Influence of psychogenetics in opiate tolerance and abstinence in mice | 0.0 | 9 | Citations (PDF) |
| 167 | Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity | 0.0 | 17 | Citations (PDF) |
| 168 | Buprenorphine: Bell-shaped dose-response curve for its antagonist effects | 0.0 | 52 | Citations (PDF) |
| 169 | Rational modulation of the innate immune system for neuroprotection in ischemic stroke | 2.7 | 200 | Citations (PDF) |
| 170 | Title is missing! 0 | | 1 | Citations (PDF) |
| 171 | Circadian Control of Neutrophils Drives Collateral Perfusion and Stroke Outcome | 13.1 | 7 | Citations (PDF) |
| 172 | DNase1 RS1053874 Polymorphism is Associated with Early Neurological Recovery through NET Modulation and with Long‐Term Survival in Ischemic Stroke: A Prospective Cohort Study | 6.6 | 0 | Citations (PDF) |
| 173 | Neuroinflammation in vascular cognitive impairment and dementia: Insights from clinical biomarkers and experimental models | 4.7 | 1 | Citations (PDF) |
| 174 | Immune System of the Ischemic Brain: Old Paradigms Revisited | 5.9 | 1 | Citations (PDF) |
